Inefficient transcription is a production bottleneck for artificial therapeutic BiTE® proteins-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inefficient transcription is a production bottleneck for artificial therapeutic BiTE® proteins

Published:2024-03 Issue: Volume:79 Page:91-99
ISSN:1871-6784
Container-title:New Biotechnology
language:en
Short-container-title:New Biotechnology

Author:

Jerabek Tobias,Burkhart Madina,Goetz Selina,Greck Benedikt,Menthe Anika,Neef Ruediger,Otte Kerstin

Funder

Amgen Inc

Ministerium für Wissenschaft Forschung und Kunst Baden-Württemberg

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Bioengineering,Biotechnology

Reference27 articles.

1. Biopharmaceutical benchmarks 2018;Walsh;Nat Biotechnol,2018

2. Biopharmaceutical benchmarks 2022;Walsh;Nat Biotechnol,2022

3. Bispecific antibodies: a mechanistic review of the pipeline;Labrijn;Nat Rev Drug Discov,2019

4. Alternative molecular formats and therapeutic applications for bispecific antibodies;Spiess;Mol Immunol,2015

5. The BiTE (bispecific T-cell engager) platform: development and future potential of a targeted immuno-oncology therapy across tumor types;Einsele;Cancer,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The new frontier in CHO cell line development: From random to targeted transgene integration technologies;Biotechnology Advances;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP